ONRIVA TRIO bexicap contains Indacaterol + Glycopyrronium + Mometasone Furoate. It is a combination inhalation medicine containing a long-acting bronchodilator and an inhaled corticosteroid used for the maintenance treatment of chronic respiratory conditions such as COPD and asthma as prescribed by a physician.
Uses:
Long-term maintenance treatment of chronic obstructive pulmonary disease (COPD).
Helps relieve symptoms such as shortness of breath, wheezing, and chest tightness.
Helps improve airflow by relaxing airway muscles.
Reduces airway inflammation.
Helps prevent worsening of respiratory symptoms.
Dose:
Adults: Usually one inhalation once daily, or as directed by a physician.
Use with the BEXICAP inhaler device as instructed by a healthcare professional.
Do not swallow the capsule; it is meant for inhalation only.
Rinse the mouth after inhalation to reduce the risk of mouth irritation.
Dose and duration depend on the patient's condition and response to treatment.